- Decreased market demand for personal protective equipment, resulting in the termination of that business segment.
- Rising production costs and lower gross profit margin for supply chain services of big health products.
- Potential climate-related risks (physical and transition risks).
- Material uncertainty related to going concern due to net losses and net current liabilities.
Sinopharm Tech Holdings Limited
Greenhouse gas emissions & sustainability report data
In its 2024 reporting, Sinopharm Tech Holdings Limited disclosed greenhouse gas emissions of 31.9K kg CO2e (indirect). By scope: Scope 2: 31.9K kg CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
31.9K kg CO2e (indirect)
2024
Energy Use
8.92 kWh
2024
📊 Emissions by Scope (2024)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 31.9K kg CO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Reduced indirect CO2 emission from electricity consumption to approximately 31,881.12kg in 2024 (2023: approximately 98,858.91kg).
- Reduced intensity of non-hazardous waste produced per business unit to 0 tonne in 2024 (2023: 0.6 tonnes per production line).
🌱 ESG Focus Areas
Environmental ManagementLabor PracticesHealth and SafetySupply Chain ManagementProduct ResponsibilityAnti-corruptionCommunity Investment